424 / | HD | DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS |
|
9.1 | | IN VIVO DIAGNOSIS OR IN VIVO TESTING {7} |
9.2 | DF | .~> Testing efficacy or toxicity of a compound or composition (e.g., drug, vaccine, etc.) |
9.3 | DF | .~> Magnetic imaging agent (e.g., NMR, MRI, MRS, etc.) {7} |
9.4 | DF | .~> X-ray contrast imaging agent (e.g., computed tomography, angiography, etc.) {5} |
9.5 | DF | .~> Ultrasound contrast agent {2} |
9.6 | DF | .~> Diagnostic or test agent produces in vivo fluorescence {1} |
9.7 | DF | .~> Diagnostic or test agent produces visible change in mouth {1} |
9.8 | DF | .~> Diagnostic or test agent produces visible change on skin {1} |